8-KEarnings & ResultsExhibits & Filings

Medtronic plc 8-K Report, Financial Results (Aug 24, 2021)

Filed August 24, 2021For Securities:MDT

Summary

Medtronic plc (MDT) filed an 8-K on August 24, 2021, to report its first quarter fiscal year 2022 financial results. This filing primarily serves to furnish the press release announcing these results, which provides investors with timely information on the company's performance. The key takeaway for investors is access to Medtronic's most recent financial performance data for the quarter ended August 2021. While the 8-K itself doesn't contain the detailed financial statements, it directs investors to the press release (Exhibit 99.1) for specifics on revenue, earnings, and other operational metrics. Investors should review this press release to understand the company's top-line growth, profitability, and any forward-looking guidance provided by management.

Key Highlights

  • 1Medtronic plc (MDT) announced its first quarter fiscal year 2022 financial results via a press release.
  • 2The 8-K filing was made on August 24, 2021, with the event date of the announcement being August 23, 2021.
  • 3The press release containing the detailed financial results is furnished as Exhibit 99.1 to the 8-K.
  • 4Investors are directed to the press release for comprehensive information on the company's financial condition and results of operations for Q1 FY2022.
  • 5This filing is a standard disclosure mechanism for significant financial events.
  • 6The report includes an interactive data file (embedded in Inline XBRL) for easier analysis of financial information.

Frequently Asked Questions

The 8-K filing itself does not contain the detailed financial results. Investors need to refer to the press release furnished as Exhibit 99.1 for specifics on revenue, earnings per share, and other key financial performance indicators for the quarter ended August 2021.

The actual financial numbers are detailed in the press release issued by Medtronic on August 24, 2021, which is attached as Exhibit 99.1 to this 8-K filing.

Forward-looking statements and guidance are typically included in the press release. Investors should review Exhibit 99.1 to ascertain any projections or outlook provided by Medtronic for the upcoming periods.

An 8-K filing is a crucial report for investors as it signals a material event for the company. In this case, it announces the release of quarterly financial results, providing timely updates on Medtronic's business performance and financial health.